Multicentre Acute Stroke Trial-Italy "MAST-I"


Phase 3 Results

Eligibility Criteria

Inclusion Criteria

Acute ischemic stroke presenting within 6 hours of symptom onset. No clear indication for or contraindication against streptokinase or aspirin.

Exclusion Criteria

Intracerebral hemorrhage, severe coma without any purposeful motor response, rapid resolution of neurological symptoms, and any medical disorders or exposure to drugs that might interfere with the safety and efficacy evaluation.